Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Lovett-Racke

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|June 27, 2012
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signalingHaiyan Peng, Mireia Guerau-de-Arellano, Veela B Mehta, et al.
Journal of Neuroimmunology|August 7, 2021
B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year reportAmy E Lovett-Racke, Yuhong Yang, Yue Liu, et al.
European Journal of Immunology|April 18, 2024
MicroRNAs targeting TGF-β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and functionChristina N Rau, Mary E Severin, Priscilla W Lee, et al.
European Journal of Immunology|October 18, 2023
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosisCora L Petersen-Cherubini, Shawn P Murphy, Matthew Xin, et al.
Brain : a Journal of Neurology|November 18, 2011
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunityMireia Guerau-de-Arellano, Kristen M Smith, Jakub Godlewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune diseaseAmy E Lovett-Racke, Rehana Z Hussain, Sara Northrop, et al.
The Journal of Experimental Medicine|June 24, 2009
T-bet is essential for encephalitogenicity of both Th1 and Th17 cellsYuhong Yang, Jeffrey Weiner, Yue Liu, et al.
Journal of Neuroimmunology|August 4, 2024
Novel model of multiple sclerosis induced by EBV-like virus generates a unique B cell populationJoshua L Deffenbaugh, Kyeong-Joo Jung, Shawn P Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune diseaseAnne R Gocke, Rehana Z Hussain, Yuhong Yang, et al.
Brain : a Journal of Neurology|May 19, 2016
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosisMary E Severin, Priscilla W Lee, Yue Liu, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|June 27, 2012
Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signalingHaiyan Peng, Mireia Guerau-de-Arellano, Veela B Mehta, et al.
Journal of Neuroimmunology|August 7, 2021
B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year reportAmy E Lovett-Racke, Yuhong Yang, Yue Liu, et al.
European Journal of Immunology|April 18, 2024
MicroRNAs targeting TGF-β signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and functionChristina N Rau, Mary E Severin, Priscilla W Lee, et al.
European Journal of Immunology|October 18, 2023
Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosisCora L Petersen-Cherubini, Shawn P Murphy, Matthew Xin, et al.
Brain : a Journal of Neurology|November 18, 2011
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunityMireia Guerau-de-Arellano, Kristen M Smith, Jakub Godlewski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune diseaseAmy E Lovett-Racke, Rehana Z Hussain, Sara Northrop, et al.
The Journal of Experimental Medicine|June 24, 2009
T-bet is essential for encephalitogenicity of both Th1 and Th17 cellsYuhong Yang, Jeffrey Weiner, Yue Liu, et al.
Journal of Neuroimmunology|August 4, 2024
Novel model of multiple sclerosis induced by EBV-like virus generates a unique B cell populationJoshua L Deffenbaugh, Kyeong-Joo Jung, Shawn P Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune diseaseAnne R Gocke, Rehana Z Hussain, Yuhong Yang, et al.
Brain : a Journal of Neurology|May 19, 2016
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosisMary E Severin, Priscilla W Lee, Yue Liu, et al.
Pageof 7